Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Cell and Developmental Biology|January 6, 2022
Targeting Metabolic Pathways of Myeloid Cells Improves Cancer ImmunotherapyJianying Li, Chelsea Bolyard, Gang Xin, et al.
Cancers|July 24, 2021
Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer TherapyMitra Nair, Chelsea Bolyard, Tae Jin Lee, et al.
Science Immunology|March 18, 2022
Transforming growth factor-β1 in regulatory T cell biologyJoshua M Moreau, Maria Velegraki, Chelsea Bolyard, et al.
Cureus|October 23, 2020
Emergency Department "Bounce-Back" Rates as a Function of Emergency Medicine Training YearJanine Curcio, Andrew Little, Chelsea Bolyard, et al.
Journal of Hematology & Oncology|June 11, 2022
Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidenceDaniel Kreatsoulas, Chelsea Bolyard, Bill X Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancerChelsea Bolyard, Ji Young Yoo, Pin-Yi Wang, et al.
The Journal of Gene Medicine|January 15, 2017
Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomideAlena Cristina Jaime-Ramirez, Nina Dmitrieva, Ji Young Yoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2013
DNA demethylating agents synergize with oncolytic HSV1 against malignant gliomasKazuo Okemoto, Kazue Kasai, Benjamin Wagner, et al.
Molecular Therapy Oncolytics|February 6, 2019
Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral EdemaBangxing Hong, Kamaldeen Muili, Chelsea Bolyard, et al.
Iscience|July 26, 2022
Sex-biased adaptive immune regulation in cancer development and therapyJohanna M Schafer, Tong Xiao, Hyunwoo Kwon, et al.
Pageof 3